A048870 Stock Overview
Engages in the research and development, and investment of generic and new drugs, medical devices, and health functional foods in South Korea.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 3/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Synergy Innovation Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩3,360.00 |
| 52 Week High | ₩4,100.00 |
| 52 Week Low | ₩2,100.00 |
| Beta | 0.40 |
| 11 Month Change | 28.49% |
| 3 Month Change | 31.76% |
| 1 Year Change | -12.50% |
| 33 Year Change | -19.81% |
| 5 Year Change | 84.11% |
| Change since IPO | -96.75% |
Recent News & Updates
Earnings Not Telling The Story For Synergy Innovation Co., Ltd. (KOSDAQ:048870) After Shares Rise 28%
Sep 09
Synergy Innovation Co., Ltd.'s (KOSDAQ:048870) Shares Climb 32% But Its Business Is Yet to Catch Up
Jul 22Synergy Innovation Co., Ltd.'s (KOSDAQ:048870) Shares Climb 32% But Its Business Is Yet to Catch Up
Jul 22Recent updates
Earnings Not Telling The Story For Synergy Innovation Co., Ltd. (KOSDAQ:048870) After Shares Rise 28%
Sep 09Synergy Innovation Co., Ltd.'s (KOSDAQ:048870) Shares Climb 32% But Its Business Is Yet to Catch Up
Jul 22Synergy Innovation Co., Ltd.'s (KOSDAQ:048870) Shares Climb 32% But Its Business Is Yet to Catch Up
Jul 22Investors Can Find Comfort In Synergy Innovation's (KOSDAQ:048870) Earnings Quality
Mar 31A Look At The Intrinsic Value Of Synergy Innovation Co., Ltd. (KOSDAQ:048870)
May 03There's Been No Shortage Of Growth Recently For Synergy Innovation's (KOSDAQ:048870) Returns On Capital
Apr 07Is Synergy Innovation Co., Ltd.'s (KOSDAQ:048870) Shareholder Ownership Skewed Towards Insiders?
Mar 11Investors Who Bought Synergy Innovation (KOSDAQ:048870) Shares A Year Ago Are Now Up 76%
Feb 13Is Synergy Innovation (KOSDAQ:048870) Using Too Much Debt?
Jan 17Here’s What’s Happening With Returns At Synergy Innovation (KOSDAQ:048870)
Dec 22Is Synergy Innovation Co., Ltd.'s (KOSDAQ:048870) Shareholder Ownership Skewed Towards Insiders?
Nov 26Shareholder Returns
| A048870 | KR Medical Equipment | KR Market | |
|---|---|---|---|
| 7D | 21.3% | -1.5% | -5.8% |
| 1Y | -12.5% | 11.1% | -4.3% |
Return vs Industry: A048870 underperformed the KR Medical Equipment industry which returned 8.8% over the past year.
Return vs Market: A048870 underperformed the KR Market which returned -3.8% over the past year.
Price Volatility
| A048870 volatility | |
|---|---|
| A048870 Average Weekly Movement | 9.6% |
| Medical Equipment Industry Average Movement | 8.0% |
| Market Average Movement | 6.6% |
| 10% most volatile stocks in KR Market | 11.9% |
| 10% least volatile stocks in KR Market | 3.4% |
Stable Share Price: A048870's share price has been volatile over the past 3 months.
Volatility Over Time: A048870's weekly volatility (10%) has been stable over the past year, but is still higher than 75% of KR stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1998 | 60 | Han-Ki Kim | www.synergyinno.com |
Synergy Innovation Co., Ltd. engages in the research and development, and investment of generic and new drugs, medical devices, and health functional foods in South Korea. It produces and sells various culture media for hospitals, pharmaceuticals, and food/cosmetics; manufactures synergy innovation – universal transport solutions (SI-UTS); and invests and develops in various fields comprising microorganism, bacteria, and virus. The company also provides pharmaceutical formulations; and develops non-vascular stents.
Synergy Innovation Co., Ltd. Fundamentals Summary
| A048870 fundamental statistics | |
|---|---|
| Market cap | ₩277.90b |
| Earnings (TTM) | ₩16.49b |
| Revenue (TTM) | ₩89.24b |
16.8x
P/E Ratio3.1x
P/S RatioIs A048870 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A048870 income statement (TTM) | |
|---|---|
| Revenue | ₩89.24b |
| Cost of Revenue | ₩54.62b |
| Gross Profit | ₩34.63b |
| Other Expenses | ₩18.13b |
| Earnings | ₩16.49b |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 199.43 |
| Gross Margin | 38.80% |
| Net Profit Margin | 18.48% |
| Debt/Equity Ratio | 12.4% |
How did A048870 perform over the long term?
See historical performance and comparison